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Abstract
Background: Medical 3D printing has demonstrated value in anatomic models for abdominal, hepatobiliary, and
gastrointestinal conditions. A writing group composed of the Radiological Society of North America (RSNA) Special
Interest Group on 3D Printing (SIG) provides appropriateness criteria for abdominal, hepatobiliary, and
gastrointestinal 3D printing indications.
Methods: A literature search was conducted to identify all relevant articles using 3D printing technology associated
with a number of abdominal pathologic processes. Each included study was graded according to published guidelines.
Results: Evidence-based appropriateness guidelines are provided for the following areas: intra-hepatic masses, hilar
cholangiocarcinoma, biliary stenosis, biliary stones, gallbladder pathology, pancreatic cancer, pancreatitis, splenic
disease, gastric pathology, small bowel pathology, colorectal cancer, perianal fistula, visceral trauma, hernia, abdominal
sarcoma, abdominal wall masses, and intra-abdominal fluid collections.
Conclusion: This document provides initial appropriate use criteria for medical 3D printing in abdominal, hepatobiliary,
and gastrointestinal conditions.
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Background
In 2018, the Radiological Society of North America (RSNA)
Special Interest Group on 3D Printing (SIG) published initial
guidelines for medical 3D printing appropriateness [1].
Those appropriateness guidelines included a number of
organ or system-based appropriateness criteria; however,
they did not include indications for abdominal, hepatobiliary,
and gastrointestinal 3D printing. Medical 3D printing has
been gaining popularity in new areas of clinical practice and
is now performed for a variety of abdominal indications [2].
However, there is no consensus on which abdominal, hepatobiliary, and gastrointestinal scenarios and indications
can most benefit from 3D printing. The purpose of this work
is to provide evidence-based appropriate use criteria for abdominal, hepatobiliary, and gastrointestinal indication for
medical 3D printing.
Methods
The SIG initiated writing groups for appropriateness of
performing 3D printing from medical imaging for various clinical conditions. This present work provides the
literature search and strength of evidence to introduce
the appropriateness of abdominal, hepatobiliary, and
gastrointestinal 3D printing for clinical utilization, research, scientific, and informational purposes. Related
work previously published and not covered in the present
work includes genitourinary and abdominal vascular conditions, which were presented in the initial appropriateness guidelines [1]. This work is loosely modeled after the
American College of Radiology (ACR) Appropriateness
Criteria® [3], in that the guidelines committee uses an
evidence-based approach at scoring. Consensus among
members is used when there is a paucity of evidence.
Strength of evidence is determined by literature review.
The SIG Guidelines Chairperson oversees the ratings
via a vote among Special Interest Group members at inperson meetings. The results of the ratings follow the following 1–9 format (with 9 being the most appropriate):
1–3, red, rarely appropriate: There is a lack of a clear
benefit or experience that shows an advantage over
usual practice.
4–6, yellow, may be appropriate: There may be times
when there is an advantage, but the data is lacking, or
the benefits have not been fully defined.
7–9, green, usually appropriate: Data and experience
shows an advantage to 3D printing as a method to
represent and/or extend the value of data contained in
the medical imaging examination.
Clinical scenarios were organized by organ systems. An
exhaustive PubMed literature search was performed
through October 2018, a strength of evidence analysis was
performed, and an appropriate use criteria document was
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generated. The supporting evidence was obtained through
structured PubMed searches, as detailed in the Appendix
1. For each category, from the pool of total results, the
number of publications considered “included results” was
initially curated by a single author with expertise in 3D
printing and abdominal imaging (DHB) then substantiated
by consensus of coauthors with expertise in 3D printing.
For the present study, only anatomic models were included for evaluation. The following categories were excluded because they were considered outside the project
scope: virtual and augmented reality, 3D printed implants,
3D printed instruments and surgical guides, bioprinting,
and bioactive printing. Abdominal 3D printing review articles were recorded, but not considered in determining
final appropriateness ratings. All final components of this
section were vetted and approved by vote of Special Interest Group members face-to-face at the 2018 Annual
Meeting of the Radiological Society of North America
(November 27, 2018, Chicago, IL, USA). Afterwards, a 2week period for comments by SIG member was posted on
the SIG’s members-only online forum. In addition, all included studies [4–49] were graded with a strength of evidence assessment according to ACR Appropriateness
Criteria Evidence Document [50].

Results
Table 1 provides evidence-based guidelines, supplemented
by expert opinion when there was a paucity of peer-review
data, to define and support the use of 3D printing for patients with abdominal, hepatobiliary, and gastrointestinal
conditions. The citations included in forming the appropriateness criteria and the strength of evidence assessment
are presented in Appendices 1 and 2 respectively.
Discussion
Hepatobiliary

The majority of intrahepatic masses requiring resection
in adults includes hepatocellular carcinoma and isolated
or few intrahepatic metastases, such as colorectal metastasis [51]. Anatomic models have been used in preoperative planning for surgical resection of hepatic masses
[19, 21, 52]. Specifically, 3D printed anatomic models
may be helpful in the resection of hepatic tumors
through demonstrating the relationship of the tumor in
regards to its location within hepatic segments, invasion
or proximity to major hepatic or portal veins, arteries,
and bile ducts. Printed models can help in choosing the
optimal resection plane and may be useful in selecting
patients at risk of posthepatectomy liver failure. Additionally, anatomic models have been used for both liver
transplant donor and recipients [20].
Biliary obstruction has benign and malignant etiologies
including strictures, extrinsic compression, stones, and
biliary malignancies. Symptomatic patients or those with
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Table 1 Appropriateness Ratings for Abdominal, Hepatobiliary, and Gastrointestinal Indications. The “Rating driven…” column
denotes if the primary decision for the condition’s rating was decided primarily through results and discussion of the literature
search or expert opinion (the latter was largely reserved for conditions with no or few supporting studies). The “Study quality”
column reflects the graded strength of evidence assessment according to ACR Appropriateness Criteria Evidence Document50
(individual ratings available in Appendix 2). The highest/most robust level of evidence is ‘Category 1’ and the lowest is ‘Category 4.’
No studies qualified for Category 1, but multiple did qualify for Category 2

laboratory derangements of obstructive jaundice or liver
dysfunction may benefit from endoscopic stones and
sludge removal, dilation, and stenting in select cases
[53]. For biliary endoscopy, previous work show 3D
printed anatomic models being used primarily in

training applications [29, 30]. 3D printing has been used
in the development of novel biliary stents [54].
Laparoscopic cholecystectomy is among one of the
most common operations performed by general surgeons, which may be performed in an acute setting for
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acute cholecystitis or electively for symptomatic cholelithiasis and other indications [55]. Percutaneous cholecystostomy is a percutaneous approach for management
of acute cholecystitis, often performed in those who are
critically ill or poor candidates for general anesthesia
[56]. The gallbladder may infrequently be a site of primary malignancy, prompting cholecystectomy (often
open and radical) in the absence of metastasis. Specific
applications of 3D printed anatomic models related to
the gallbladder have not been published through the extent of our literature search.
Pancreas and spleen

Pancreatic cancer is the fourth leading cause of cancer
death in the United States and typically caries a poor
prognosis with a 3% 5-year survival rate [57]. Resections
of pancreatic tumors are challenging operations with
high rates of morbidity [58]. To this end, 3D printed
anatomic models to delineate tumor anatomy may be of
use and have been published in cases series for pancreatic cancer applications [34–37].
There are a number of mucinous and serous pancreatic neoplasms, some of which may be indicated for surgical resection [59]. One educational series fabricated a
3D printed anatomic model for a pancreatic tail mucinous neoplasm, although this was not used in the patient’s preoperative planning [34].
Pancreatitis is an inflammatory response of the pancreas most commonly due to alcoholism and obstruction
of the pancreatic duct. This condition is a clinical diagnosis by symptomatology and laboratory derangements. Imaging can be used to help confirm the diagnosis or assess
for complications. Complications requiring percutaneous,
endoscopic, and infrequently surgical management include infected peripancreatic fluid collections, walled off
pancreatic necrosis, and other less frequent etiologies [60].
Specific applications of 3D printed anatomic models related to pancreatitis or its complications have not been
published through the extent of our literature search.
Elective splenectomy is often performed for
hematologic conditions, as part of larger operations (typically cancer adjacent cancer resections), or, rarely, due
to splenic masses with indications for resection. There
have been two cases series involving 3D printed anatomic models [36, 40], one of which was used in the
process of patient consent [40].
Gastrointestinal

The incidence of gastric cancer has decreased worldwide
with improved detection and treatment of Helicobacter
pylori and availability of endoscopy. However, gastric
cancer remains a morbid diagnosis and cause of cancer
death [61]. Peptic ulcer disease is a prevalent condition,
often treated medically and occasionally further
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characterized with endoscopy [53]. Published uses of
anatomic models in gastric pathology largely encompass
simulation of endoscopy or surgery [41, 42].
Small bowel tumors are relatively uncommon, most
commonly due to adenocarcinoma, gastrointestinal stromal tumor, carcinoid tumor and lymphoma. These may
present with abdominal pain, small bowel obstruction,
or without symptoms [62]. In North America, small
bowel obstruction most commonly occurs due to postoperative adhesions. Other causes include incarcerated
hernias, strictures, and malignant obstruction [63]. Specific applications of 3D printed anatomic models related
to small bowel pathology have not been published
through the extent of the literature search.
Colorectal cancer is the third most common cause of
cancer death in the United States [57]. Treatment strategies
vary considerably according to anatomic location, staging,
among other factors [64]. 3D printed anatomic models have
shown some utility in delineating relevant surgical anatomy
for resection of colorectal cancer [45, 46].
Anorectal fistulae and abscesses are abnormal tracts
and collections about the anus and rectum that occur
with greater frequency in patients with Crohn disease
[65]. Frequently, pelvic MRI may be obtained to delineate anatomy for treatment planning. In one feasibility
series, 3D printed models were used to demonstrate
anatomy of anorectal fistulae [48].
Visceral abdominal trauma

Blunt and penetrating abdominal trauma may result in
life-threatening visceral trauma requiring resuscitative
efforts and exploratory laparotomy. With current 3D
printing technology, the time needed to segment and
print anatomic models is currently too lengthy for use in
traumatic conditions requiring immediate treatment.
Accordingly, our literature search yielded no relevant results regarding the use of 3D printed anatomic models
in visceral abdominal trauma.
Miscellaneous abdominal conditions

Elective hernia repair is among the most common operations performed by general surgeons [66]. Diagnosis is
often by physical examination and imaging infrequently
plays a part in diagnosing hernias. However, although
anatomic models have not been published for preoperative planning of hernias, 3D printing has facilitated a
training system in one published series [49]. 3D printing
technologies have been used in the design of novel surgical meshes [67, 68].
Sarcomas are aggressive tumors, often locally advanced
at the time of diagnosis. They may occur anywhere in the
body. In the abdomen, sarcomas may be retroperitoneal,
intra-abdominal, or affect the abdominal wall [69]. Although 3D printed anatomic models could potentially be
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helpful in planning surgical approaches, our search yielded
no results for abdominal sarcomas. One case series described anatomic models used for treatment planning in a
mediastinal/intrathoracic sarcoma [70].
Abdominal wall masses are most frequently benign
and include fibromatosis (desmoid tumor) and endometriosis. Malignant causes are most frequently metastases
or sarcomas [69, 71]. Specific applications of 3D printed
anatomic models related to abdominal wall masses have
not been published through the extent of our literature
search.
Intra-abdominal fluid collections with indications for
drainage are frequently managed with image-guided percutaneous drainage [72]. There is often acuity in time to
drainage, which may account for the lack of publications
related to 3D printed anatomic models delineating intraabdominal fluid collections. Accordingly, our literature
search yielded no results.
Limitations
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of the RSNA 3D printing Special Interest Group, will
provide a reference for clinical standards of 3D printing.
The document will be periodically refined, based on
expanding clinical applications and growing medical
literature.
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